Graphical Abstract Highlights
INTRODUCTION
Centriole biogenesis in vertebrate cycling cells follows a stereotypical program (Fırat-Karalar and Stearns, 2014; Fu et al., 2015) . Cells begin G1 phase with two preexisting centrioles, both of which are capable of recruiting the pericentriolar material (PCM) and thereby functioning as the centrosome or microtubule-organizing center (MTOC). In S phase, the two MTOCcompetent centrioles duplicate, each generating one daughter centriole that is incapable of recruiting the PCM (MTOC noncompetent) and thus must be tightly attached, or engaged, to its mother for proper segregation in mitosis . Duplication starts with the formation of the cartwheel, a 9-fold symmetric scaffold forming the base of the daughter centriole.
The newborn, MTOC-non-competent daughter centriole is itself unable to duplicate and can further suppress the duplication potential of the mother centriole to which it is tightly engaged (Loncarek et al., 2008; , strictly limiting centriole duplication to once per cell cycle. At the end of cell cycle, daughter centrioles are converted to centrosomes (MTOC competent) , disengaged from their mothers (Kuriyama and Borisy, 1981) , and removed of the cartwheel (Vorobjev and Chentsov, 1980; Vorobjev and Chentsov YuS, 1982) , all of which depend on polo-like kinase 1 (Plk1) , transforming to mother-like centrioles in the following G1 phase. Centriole-to-centrosome conversion and centriole disengagement, respectively, license daughter and mother centrioles for duplication (Fu et al., 2016; Novak et al., 2014; , but the underlying reason for cartwheel removal is not fully clear.
The newborn (MTOC non-competent) centrioles are ''sterile,'' as they lack the PCM and PCM-associated components such as CEP152 essential for duplication (Cizmecioglu et al., 2010; Dzhindzhev et al., 2010; Fu et al., 2016; Hatch et al., 2010; Novak et al., 2014; . In contrast, it is not understood how mother (MTOC-competent) centrioles also cease to duplicate when they are engaged to newborn centrioles. It has been shown that cells have no arithmetic ability to count the centriole number (Wong and Stearns, 2003) but can somehow differentiate the property intrinsic to duplicated centrioles from that of unduplicated centrioles, allowing ''duplication'' and ''block for re-duplication'' to occur simultaneously in the same cytoplasm (Wong and Stearns, 2003) . It is possible that the physical property of the engagement, which holds two centrioles closely in short distances (Shukla et al., 2015) , blocks reduplication. Alternatively, a specific chemical property intrinsic to newborn centrioles may serve as the ''mark'' of duplicated centrioles and locally suppress further duplication of the engaged mother. The molecular identity of such a mark, however, is unknown.
Interestingly, the cartwheel that forms and stabilizes newborn centrioles throughout S/G2 phase (Izquierdo et al., 2014 ) is removed during mitosis before these centrioles support duplication in the following S phase. The pattern of cartwheel assembly or disassembly correlates nicely with the formation or relief of the (C) The serial loss of cartwheel components from canonically duplicated newborn centrioles at indicated time points after PLK4 inactivation was characterized using the indicated antibodies. Top: centrioles from DMSO control treatment. Bottom: three representative images of PLK4 inactivation by 3MB-PP1 at each time point.
(D) Superresolution 3D-SIM image of acetylated tubulin, centrin, and C-Nap1 in S phase centrioles after 12 hr of control treatment (DMSO, top) or PLK4 inactivation (bottom).
(legend continued on next page) duplication block during the cell cycle, raising a testable model that perhaps the cartwheel is the ''mark'' of the newborn centriole constituting the block. It has been reported that the centriolar protein SAS-6 and its binding partner STIL form the cartwheel (Cottee et al., 2015; Kitagawa et al., 2011; Qiao et al., 2012; van Breugel et al., 2011) in a process catalyzed by the polo-like kinase PLK4 (Arquint et al., 2015; Dzhindzhev et al., 2014; Kratz et al., 2015; Moyer et al., 2015; Ohta et al., 2014) and that loss of the cartwheel during mitosis depends on Plk1 and Cdk1 (Arquint and Nigg, 2014) . Here, we aim to disrupt cartwheel dynamics through manipulations of PLK4 and STIL, with a goal to determine whether the cartwheel is involved in the block for centriole reduplication.
RESULTS

Persistent PLK4 Activity Stabilizes the Cartwheel and Newborn Centrioles
To address cartwheel dynamics and maintenance after centriole duplication has occurred, a number of retinal pigment epithelial (RPE1) cell lines in which PLK4 can be conditionally removed or inactivated were made (see Table S1 and Experimental Procedures for details). We generated PLK4 flox/neoflox cells in which the endogenous, wild-type PLK4 can be conditionally deleted by expression of the Cre recombinase, a derived cell line in which the endogenous Plk4 is deleted, and an analog-sensitive mutant (PLK4 as ) that can be chemically inactivated by bulky ATP analog is expressed under the tetracycline inducible promoter (PLK4 À/À ; tet-PLK4 as ; see Figure S1 and Supplemental Experimental Procedures for details). To ensure proper expression of PLK4 as under the endogenous promoter, we also obtained a PLK4 as knockin cell line (PLK4 as KI; unpublished data), similar to the DLD-1 cell line recently reported (Moyer et al., 2015) . Moreover, using these cells, we constructed other derived cell lines in which the endogenous p53 and STIL were inactivated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 gene targeting, generating acentriolar cell lines in which centrioles made of different forms of STIL can be subsequently reconstituted (Table S1 ) (Izquierdo et al., 2014; Wang et al., 2015) . For clarity, the brief name of each cell line is used in the main text, and detailed genetic information is listed in Table S1 . We first examined if cartwheel maintenance requires constant PLK4 activity in PLK4 as cells (PLK4 À/À ; tet-PLK4 as ) arrested at S phase, when the cartwheel is present in every newborn daughter centriole ( Figure 1A ). Unlike control cells always carrying two pairs of duplicated centrioles in which the newly formed daughter was labeled with STIL or SAS-6 ( Figure 1C , top row), inactivation of PLK4 resulted in serial losses of the cartwheel components from daughter centrioles ( Figures 1C and 1I ). Specifically, 1 hr after PLK4 inactivation, $50% of daughter centrioles lost STIL ( Figure 1C , second row); by 4 hr, a similar loss of SAS-6 was observed ( Figure 1C , third row), consistent with the previous report (Moyer et al., 2015) . Moreover, after 12 hr, daughter centrioles started to disappear ( Figure 1C , bottom row; Figures 1D and 1I ), leaving behind two single mother centrioles each of which was labeled with centrin, C-Nap1, and acetylated alpha tubulin, as revealed by superresolution microscopy (3D-SIM) ( Figure 1D ). This is consistent with our previous report that the cartwheel is required to stabilize newborn centrioles (Izquierdo et al., 2014) . Rapid losses of STIL and SAS-6 from the cartwheel upon PLK4 inactivation were also observed with PLK4 as knockin RPE1 cells (PLK4 as KI) ( Figure 1J ). Note that in the absence of the cartwheel, daughter centrioles remained engaged to the mother centriole before they eventually lost stability ( Figure 1C , second and third row). The requirement of PLK4 in stabilizing the cartwheel was also seen for de novo centrioles ( Figures 1E, 1H , and 1K), which were reconstituted in PLK4 as ; p53
À/À cells ( Figure 1B ; Table S1 ). Interestingly, the loss of SAS-6 and centrin from de novo centrioles upon PLK4 inactivation occurred much faster than that from canonically duplicated centrioles ( Figures 1I-1K ). After 4 hr of PLK4 inactivation, the number of de novo centrioles, as judged by centrin and CPAP staining, dropped from 59 per cell on average before PLK4 inactivation to 11 per cell. These results together suggest that the cartwheel is a dynamic structure requiring constant maintenance by PLK4 and that cartwheel maintenance is essential for the long-term stability of newborn centrioles.
Phosphomimetic STIL Supports Centriole Assembly Only When PLK4 Is Present Recent studies showed that phosphorylation of STIL by PLK4 drives cartwheel assembly (Dzhindzhev et al., 2014; Kratz et al., 2015; Moyer et al., 2015; Ohta et al., 2014) . While the four critical residues phosphorylated by PLK4 (S1061, S1111, S1116, and T1119) are conserved between human and Drosophila (Dzhindzhev et al., 2014) , it is unclear if phosphomimetic STIL can bypass the requirement of PLK4 for centriole assembly. , successfully rescued de novo centriole formation, as revealed by centrin, STIL, and SAS-6 staining ( Figures 2A-2C , left and center). Conversely, when PLK4 was inactivated, none of the constructs, including STIL 4D , could drive de novo centriole formation ( Figures 2A-2C , right). These results together indicate that while (E-H) De novo formed centrioles in S phase were treated with DMSO (E and G) or inhibited of PLK4 (F and H) and analyzed by immunofluorescence microscopy using the indicated antibodies. Upon PLK4 inactivation, cartwheel components STIL and SAS-6 (F), but not the core centriolar component CPAP (H), were quickly lost. Note also that the number of de novo centrioles (centrin/CPAP foci) was dramatically reduced after 3MB-PP1 treatments (F and H), faster than that for canonical centrioles (see I-K). and 2E; Table S1 ). We thus examined the effect of PLK4 inactivation in these two cell lines arrested in S phase. As expected, STIL WT -derived centrioles quickly lost cartwheel integrity upon PLK4 inactivation, as indicated by loss of STIL or SAS-6 ( Figures 3A and 3B ). In contrast, surprisingly, the cartwheel made of STIL 4D could stably exist in newborn centrioles in the absence of PLK4 activity, retaining STIL, SAS-6, and other centriolar components (Figures 3A and 3B ; data not shown). In addition to canonical centrioles, a similar PLK4-independent stabilization of the cartwheel by STIL 4D is also seen in de novo centrioles reconstituted in PLK4 as ; STIL WT or 4D cells (Table S1 ; Figures 3C  and 3D ). Moreover, to confirm that our observation is not due to a nonspecific effect of the PLK4 analog-sensitive mutation, we inactivated PLK4 with the recently reported small molecule inhibitor centrinone Table S1 ). Consistently, centrinone treatment caused serial losses of the cartwheel components from STIL WT centrioles, but not from centrioles made of STIL 4D ( Figure 3E ). Interestingly, while the STIL 4D -derived cartwheel is stable in the absence of PLK4, it is still efficiently removed from daughter centrioles during mitosis ( Figure 3F ), indicating that other mechanisms are involved in normal cartwheel removal (Arquint and Nigg, 2014) . Together, our data indicate that phosphomimetic STIL can bypass the requirement of PLK4 for cartwheel maintenance, but not for centriole assembly, suggesting that perhaps PLK4 Error bars represent SD; n > 25, N = 3. ***p < 0.001; n.s., non-significant (two-tailed t test 
(legend continued on next page)
has additional substrates involved in other steps of centriole biogenesis.
Loss of the Cartwheel from Daughter Centrioles Induces Reduplication of the Mother Centriole
Inactivation of PLK4 induces rapid loss of the cartwheel components from daughter centrioles ( Figure 1J ). To test if constant maintenance of an intact cartwheel is required for the block of reduplication, PLK4 activity was resumed after cartwheel loss. A caveat of this procedure is that inactivation of PLK4 also results in gradual accumulation of PLK4 at centrosomes (CunhaFerreira et al., 2013; Guderian et al., 2010; Klebba et al., 2013) , leading to centriole over-duplication upon PLK4 reactivation. To inactivate PLK4 without causing its accumulation, cells were treated with cycloheximide (CHX) to block protein synthesis, shortly before and during PLK4 inhibition ( Figure 4A ). As expected, in the absence of new translation, PLK4 levels at the centrosome after PLK4 inhibition stayed the same ( Figure 4B ), unlike cells untreated with CHX. Note that PLK4 and protein synthesis were inhibited for 1 hr only, followed by PLK4 reactivation ( Figure 4A ), as long-term inhibition of protein synthesis caused non-specific adverse effects on cells (data not shown). Intriguingly, 2 hr after restoring PLK4 activity and protein synthesis, all preexisting daughter centrioles, which were still engaged to the mother centriole ( Figure 4C , second row), regained intact cartwheels (100%), as revealed by STIL and SAS-6 staining. Moreover, we consistently saw that $20% of mother centrioles reduplicated, carrying two engaged daughter centrioles, one preexisting and one newly formed, both equipped with the cartwheel containing STIL and SAS-6 (Figures 4C, third and fourth row, and 4F, left). To further test if the reduplication of mother centrioles depends on loss of STIL from the daughter, we repeated the same assay in cells where daughter centrioles were made of the exogenous STIL 4D or STIL WT as the control (Figures 4D and 4E) . Strikingly, whereas a significant fraction of mother centrioles engaged to STIL WT daughter centrioles reduplicated after a transient PLK4 inactivation and reactivation ( Figure 4D ; Figure 4F , center), very few mother centrioles engaged to STIL 4D daughter centrioles reduplicated ( Figure 4E ; Figure 4F , right). Importantly, the stochastic nature of the reduplication (i.e., not all mother centrioles losing the associated cartwheel could reduplicate) is consistent with the principle of the duplication control (see Figure 4G and Discussion). Collectively, our results suggest that loss of intact cartwheel, or STIL, from daughter centrioles can induce stochastic reduplication of the engaged mother centriole in the same S phase, leading to overproduction of centrioles. Thus, the intact cartwheel carried by the daughter centriole constitutes a critical part of the duplication block, which is specifically tethered to mother centrioles through the engagement to locally suppress reduplication.
DISCUSSION
Phosphorylation of STIL by PLK4 drives cartwheel assembly for centriole duplication (Dzhindzhev et al., 2014; Kratz et al., 2015; Moyer et al., 2015; Ohta et al., 2014) , which occurs only once per cell cycle. Our results here showed that cartwheel maintenance at the newborn daughter centriole is essential for the duplication block, requiring persistent PLK4 activity. Inactivation of PLK4 after duplication causes rapid loss of cartwheel components from daughter centrioles. Resuming PLK4 activity, intriguingly, induces cartwheel assembly not only back to the preexisting daughter centriole but also, stochastically, at a new site around the mother, where the second daughter forms. Conversely, the cartwheel made of phosphomimetic STIL can exist stably, continuously exerting duplication block independent of PLK4. Thus, PLK4 not only promotes centriole duplication but also preserves the ''mark'' of duplicated centrioles, the cartwheel, to prevent reduplication, revealing a counterintuitive control in which ''assembly'' and ''block for new assembly'' are both driven by the same machinery to ensure homeostasis. We reason that the reduplication process induced by loss of cartwheel integrity occurs stochastically through one of the following two routes ( Figure 4G ): First, the intact cartwheel is rebuilt in the preexisting daughter centriole, where it exerts a block for reduplication, leading to stabilization of only one daughter centriole. In the second route, the cartwheel is randomly formed at a new site around the mother and quickly establishes a block for reduplication, but it has no effect on the recruitment of cartwheel components back to the preexisting daughter, leading to stabilization of two daughter centrioles. It is likely that the first route is preferred, as the preexisting daughter still carries some cartwheel components, such as PLK4 or SAS-6, which may provide high-affinity binding sites for efficient reassembly. The stochastic nature of the process is consistent with the basic principle of the ''once-only'' control for centriole duplication and, more importantly, is supported by our observations that only a fraction of mother centrioles losing the cartwheel from the associated daughter could reduplicate to form the second daughter.
How does the cartwheel locally block the duplication potential of the mother centrioles to which it is engaged? A recent model proposes that STIL-bound PLK4 at the cartwheel may specifically target the PCM-bound (or CEP152-bound) PLK4 around the mother centriole for degradation and thereby suppress centriole reduplication (Arquint et al., 2015; Ohta et al., 2014) . ) regardless of the treatment (see Figure 2E ). **p < 0.01; n.s., nonsignificant (two-tailed t test). (G) Stochastic nature of centriole reduplication. In normal S phase (top), the cartwheel is actively maintained at the daughter centriole by PLK4 and exerts a block for reduplication. When PLK4 is inactivated (bottom) the cartwheel fails to remain and the mother centriole is relieved from the reduplication block. Once PLK4 activity is resumed, an intact cartwheel can be rebuilt in the preexisting daughter centriole and exert an immediate duplication block (route 1). Alternatively, the cartwheel can randomly form at a new site around the mother, resulting in the formation of an additional daughter centriole and establishing a block for reduplication (route 2). However, the recruitment of the cartwheel component back to the preexisting daughter centriole is unaffected, leading to stabilization of the two daughter centrioles.
This model was deduced from observations that PLK4 can induce self-destruction through trans-autophosphorylation (Cunha-Ferreira et al., 2013; Guderian et al., 2010; Holland et al., 2010; Klebba et al., 2013) , that the kinase activity of PLK4 is greatly enhanced by binding to STIL (Moyer et al., 2015) , and that the binding of PLK4 to STIL prevents PLK4 from selfdestruction (Arquint et al., 2015; Ohta et al., 2014) . Consistent with this model, overexpression of PLK4 or STIL should and is indeed known to alleviate the duplication block, allowing multiple daughters to be born by the same mother. However, in this case, the model would also predict that when more daughter centrioles are born, more cartwheel-associated inhibitory activities would arise to counteract PLK4 at the mother centriole, which in turn would require even higher levels of PLK4 to drive the formation of more daughter centrioles, explaining why a higher level of PLK4, rather than a longer period of time in S phase, is the key to amplify daughter centrioles. Our studies here provide us an angle at which the model can be tested, and the results are largely consistent. More efforts are required to engineer specific reagents and tools to fill in the remaining gap.
EXPERIMENTAL PROCEDURES
Details of experimental procedures regarding cell culture, drug treatment, antibodies, microscopy, immunoblots, and statistical analysis are provided in Supplemental Experimental Procedures.
Transgenic Cell Lines and Plasmid Constructs
To generate PLK4 conditional knockout cell lines, exon 3 and 4 of PLK4 were targeted by adeno-associated virus (AAV)-mediated homologous recombination as described previously (Moyer et al., 2015) . CRISPR/Cas9-mediated gene targeting was used to inactivate p53, STIL, or both in various cell lines (see Table S1 ), as described previously (Izquierdo et al., 2014 ; tet-PLK4 as ; p53 -/-cell. AdCre infected cells were cultured for more than a week (left), then were supplied with a high concentration of doxycycline (center), or high doxycycline with 3MB-PP1(right). Centrioles are stained with the indicated antibodies. 
Supplemental
Supplemental Experimental Procedures
Transgenic cell lines and plasmid constructs PLK4 flox/neoflox cells were generated by Adeno-associated virus (AAV)-mediated homologous recombination as described previously ). Template genomic DNA was from RPCI-11 human BAC clone, 398H1 (Invitrogen). Primers used in the targeting process are listed below. ; tet-PLK4 as cells were then infected with adenovirus expressing Cre recombinase (AdeCre) to deplete endogenous PLK4, plated in 96 well plates, and cultured in the media containing 5 ng/ml of doxycycline to generate stable PLK4 -/-; tet-PLK4 as cell lines that carry normal number of centrosomes.
Various STIL -/-; p53 -/-cells inducibly expressing exogenous STIL WT or 4D were generated through lentiviral based transduction as described above, and isolated clonally. The targeting sequences of gRNAs used for CRISPR are as follows: p53 (5'-GGGCAGCTACGGTTTCCGTCTGG-3') and STIL (5'-GTGTGGAATTTGACTTGCATTGG-3').
PLK4
- ; tet-PLK4 as ; p53 -/-; STIL -/-cells were infected with lentivirus carrying doxycycline-inducible STIL WT, 4A, and 4D , followed by deletion of the endogenous PLK4 with AdeCre. Wild type STIL construct (Openbiosystems) and PLK4 construct (Origene RC206015) were used for subcloning into pLVX-Tight-Puro vector (Clonetech). STIL 4D/4A (S1061D/A, S1111D/A, S1116D/A, and T1119D/A) or PLK4 as (L89G) mutant constructs were created with site-directed mutagenesis (Stratagene).
Cell culture RPE1 cells were cultured in DME/F12 (1:1) medium supplemented with 10% FBS and 1% penicillinstreptomycin. PLK4 as cells (PLK4 -/-; tet-PLK4 as ) carrying centrosomes were grown under constant supply of 5 ng/ml of doxycycline. STIL 4D and PLK4 as KI; STIL 4D cell lines were grown under constant supply of 20 ng/ml of doxycycline. STIL WT and PLK4 as KI; STIL WT cell lines were grown under 5 ng/ml of doxycycline. For S-phase arrest, cells were treated with 2 µg/ml aphidicolin for 12-18 hours. S-phase cells were labeled by BrdU for 30 minutes.
Assay and drug treatment
To inhibit PLK4 as in PLK4 as cells, excess amounts of 3MB-PP1 (20 µM, EMD Millipore) was used; to inactivate PLK4 as followed by reactivation, 0.2 µM of 3MB-PP1 was used to ensure proper drug washout. To inactivate endogenous PLK4, 0.2 µM of centrinone was used . To inhibit protein translation, 1 µg/ml of CHX was used. For reduplication assay, PLK4
as KI cells pretreated with 1 µg/ml CHX for 10 minutes were additionally treated with 0.2 µM of 3MB-PP1 for 1 hour. Cells were then thoroughly washed 4 times with buffers in the absence of drugs, followed by incubation in the regular medium for 2 hours.
Antibodies
Mouse monoclonal antibodies used in this study are anti-centrin2 (clone 20H5; 04-1624, Millipore), anti-SAS-6 (sc-81431, Santa Cruz Biotechnology), anti-acetylated alpha tubulin (clone 6-11B-1; T7451, SigmaAldrich), anti-alpha tubulin (clone DM1A, Sigma-Aldrich). A rabbit polyclonal antibody against the human C-Nap1 was produced as previously described . Other rabbit polyclonal antibodies used include anti-CPAP (Proteintech), anti-STIL (Bethyl Laboratories), and anti-PLK4 (kind gift from Andrew Holland at Johns Hopkins University). PLK4 and STIL antibodies were pre-adsorbed by incubating with excess amounts of methanol fixed PLK4 -/-; p53 -/-and STIL -/-; p53 -/-cells, respectively to
